| Literature DB >> 20428306 |
Elisa F Cascade1, Amir H Kalali, David Feifel.
Abstract
We investigated use of Daytrana in the first year post-launch in the US: May, 2006 through April, 2007. According to our data, a total of 512,085 prescriptions for Daytrana were written in the first year of launch; psychiatry accounted for 34 percent of these prescriptions. Children and adolescents represented 88 percent of Daytrana users as compared to only 57 percent for the broader ADHD market. Expert commentary describing these trends is provided.Entities:
Keywords: ADHD; Daytrana; attention deficit hyperactivity disorder; methylphenidate transdermal system; patch
Year: 2007 PMID： 20428306 PMCID： PMC2860521
Source DB: PubMed Journal: Psychiatry (Edgmont) ISSN： 1550-5952